Prediction of clinical benefit from androgen deprivation therapy in salivary duct carcinoma patients

Androgen deprivation therapy (ADT) is first‐line palliative treatment in androgen receptor‐positive (AR+) salivary duct carcinoma (SDC), and response rates are 17.6–50.0%. We investigated potential primary ADT resistance mechanisms for their predictive value of clinical benefit from ADT in a cohort...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Int J Cancer
Main Authors: van Boxtel, Wim, Verhaegh, Gerald W., van Engen‐van Grunsven, Ilse A., van Strijp, Dianne, Kroeze, Leonie I., Ligtenberg, Marjolein J., van Zon, Hans B., Hendriksen, Yara, Keizer, Diederick, van de Stolpe, Anja, Schalken, Jack A., van Herpen, Carla M.
Format: Artigo
Sprog:Inglês
Udgivet: John Wiley & Sons, Inc. 2019
Fag:
Tumor Markers and Signatures
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7187215/
https://ncbi.nlm.nih.gov/pubmed/31745978
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ijc.32795
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker